Do Your Diligence: M&A Considerations Following OIG’s Special Fraud Alert on Telemedicine

Any entities that plan to invest or are already invested in digital health companies, entities that contract with them, or providers that offer in-house telehealth modalities must be aware of the significant regulatory oversight the industry faces.